Investing in rapidly expanding biotech stocks can be a worthwhile long-term investment. Just one successful drug or device can propel a biotech company to new heights. And biotech companies that use cutting-edge technology or treat complex diseases will always be in demand.
One such company is Eli Lilly (LLY), a global pharmaceutical leader that has been a standout performer in the stock market in recent years. Over the past 10 years, the stock has increased by 1,035.2%. It is known for developing ground-breaking treatments for autoimmune diseases, cancer, obesity, Alzheimer’s, diabetes, skin diseases, and other conditions.
